Plasmacure, located in Nijmegen, the Netherlands, has raised €6M in Series A funding from a strategic consortium, primarily led by U.S.-based Venture Medical. This investment will aid in advancing the PLASOMA cold plasma system, designed for complex wound treatments. Venture Medical aims to facilitate regulatory approvals and U.S. market support totaling over $10M. The funding will propel global expansion and adoption of the PLASOMA system, targeting serious conditions like diabetic foot ulcers and pressure ulcers, thereby addressing the needs of patients with hard-to-heal wounds.
Plasmacure has secured €6M in Series A funding from a consortium led by Venture Medical to expand globally and enhance complex wound treatments.
The investment will enable Plasmacure to promote PLASOMA for treating complex wounds like diabetic foot ulcers and define a new global standard in wound care.
Collection
[
|
...
]